Bloomberg the Company

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Follow Us

Industry Products

  • Exchange: New York
  • Sector: Health Care
  • Industry: Health Care Facilities & Svcs
  • Sub-Industry: Health Care Services

Charles River Laboratories International Inc

+ Add to Watchlist

CRL:US

69.3500 USD 0.4100 0.59%

As of 20:04:08 ET on 01/30/2015.

Snapshot for Charles River Laboratories International Inc (CRL)

Open: 69.5900 Day's Range: 69.0000 - 70.4700 Volume: 233,170
Previous Close: 69.7600 52wk Range: 49.6000 - 70.7300 1-Yr Rtn: +22.68%

Stock Chart for CRL

No chart data available.
  • CRL:US 69.3500
  • 1D
  • 1M
  • 1Y
69.7600
Interactive CRL Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for CRL

Current P/E Ratio (ttm) 26.0371
Estimated P/E(12/2014) 20.4512
Relative P/E vs. SPX 1.4821
Earnings Per Share (USD) (ttm) 2.6635
Est. EPS (USD) (12/2014) 3.3910
Est. PEG Ratio 2.0933
Market Cap (M USD) 3,254.02
Shares Outstanding (M) 46.92
30 Day Average Volume 340,311
Price/Book (mrq) 4.8385
Price/Sale (ttm) 2.5802
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 02/10/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for CRL

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for CRL

Charles River Laboratories International, Inc. provides research tools and support services that enable drug discovery and development. The Company pro- vides the animal research models required in research and development for new drugs, devices, and therapies. Charles River's customers include pharmaceutical and biotechnology companies, hospitals, and academic institutions.

James C FosterChairman/President/CEODavid P JohstCAO/Exec VP:Human Resources
Thomas F AckermanExec VP/CFONancy A GillettExec VP/Chief Scientific Ofcr
More Company Profile & Key Executives for CRL

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil